1. |
余年, 狄晴. 自身免疫性癫痫研究进展. 中华神经科杂志, 2017, 50(2): 152-521.
|
2. |
Levite M. Autoimmune epilepsy. Nature Immunology, 2002, 3(6): 500.
|
3. |
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58(4): 512-521.
|
4. |
Granata T, Cross H, Theodore W, et al. Immune-mediated epilepsies. Epilepsia, 2011, 52(Suppl 3): 5-11.
|
5. |
陶婷婷, 凌振芬. 抗癫痫药物的致癫痫作用. 临床神经病学杂志, 2012, 25(1): 71-72.
|
6. |
Quek AM, Britton JW, Mc Keon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol, 2012, 69(5): 582-593.
|
7. |
甘颖妍, 梁惠慈, 曾意茹, 等. 自身免疫性癫痫的临床特征及预后. 广西医学, 2018, 40(13): 1454-1456+1460.
|
8. |
Michel Toledano, Sean J Pittock. Autoimmune epilepsy. Seminars in Neurology, 2015, 35(3): 245-258.
|
9. |
Joseph J Melvin, H Huntley Hardison. Immunomodulatory treatments inepilepsy. Seminars in Pediatric Neurology, 2014, 21(3): 232-237.
|
10. |
Nociti V, Frisullo G, Tartaglione T, et al. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment. Eur J Neurol, 2010, 17(1): e5.
|